Par Drugs and Chemicals Limited — Important, 22-10-2024: Updates

Par Drugs and Chemicals Limited's Board meeting approved the unaudited financial results for the quarter and half-year ending September 30, 2024. The company reported a total revenue of ₹3,567.29 lakhs, with a profit after tax of ₹859.58 lakhs. Additionally, the Board authorized the publication of results in select newspapers, noted zero investor grievances, and reviewed corporate governance for the quarter. The trading window for securities will reopen after 48 hours post-announcement.